Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial.
about
Ebola and its control in Liberia, 2014-2015The 2014–2015 Ebola outbreak in West Africa: Hands OnInfectious diseases. Beyond EbolaVaccinology in the third millennium: scientific and social challengesA Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVAPhase 1 Trials of rVSV Ebola Vaccine in Africa and EuropeA Recombinant Vesicular Stomatitis Virus Ebola Vaccine — Preliminary ReportCritical role of ethics in clinical management and public health response to the West Africa Ebola epidemicEbola virus disease and critical illness.Clinical development of Ebola vaccinesEbolavirus Evolution: Past and PresentParticulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogensTransforming Clinical Data into Actionable Prognosis Models: Machine-Learning Framework and Field-Deployable App to Predict Outcome of Ebola PatientsOptimal control analysis of Ebola disease with control strategies of quarantine and vaccinationEfficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)Carrion's disease: an eradicable illness?Chikungunya, Influenza, Nipah, and Semliki Forest Chimeric Viruses with Vesicular Stomatitis Virus: Actions in the BrainNeurological Complications of Ebola Virus InfectionEvaluating interventions for Ebola: The need for randomized trialsRisk factors for transmission of Ebola or Marburg virus disease: a systematic review and meta-analysisTransmissibility and Pathogenicity of Ebola Virus: A Systematic Review and Meta-analysis of Household Secondary Attack Rate and Asymptomatic InfectionPreparing for Serious Communicable Diseases in the United States: What the Ebola Virus Epidemic Has Taught UsBoth Epistasis and Diversifying Selection Drive the Structural Evolution of the Ebola Virus Glycoprotein Mucin-Like DomainEpigraph: A Vaccine Design Tool Applied to an HIV Therapeutic Vaccine and a Pan-Filovirus VaccineBolstering community cooperation in Ebola resurgence protocols: combining field blood draw and point-of-care diagnosisA two-dose heterologous prime-boost vaccine regimen eliciting sustained immune responses to Ebola Zaire could support a preventive strategy for future outbreaksVaccine testing for emerging infections: the case for individual randomisationThe contribution of biological, mathematical, clinical, engineering and social sciences to combatting the West African Ebola epidemicA review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines?Global research trends of World Health Organization's top eight emerging pathogens.[Back to the Future. Vaccine trials against Ebola in the history of resistance to immunization].Lessons from the Ebola Outbreak: Action Items for Emerging Infectious Disease Preparedness and Response.The 2014 Ebola virus disease outbreak in Pujehun, Sierra Leone: epidemiology and impact of interventions.Insights from clinical research completed during the west Africa Ebola virus disease epidemic.Ebola and Marburg virus vaccines.Key data for outbreak evaluation: building on the Ebola experience.A Perspective on the Development of Plant-Made Vaccines in the Fight against Ebola VirusProspects for a Zika Virus Vaccine.Monoclonal antibodies for the treatment of Ebola virus disease.Ebola virus - from neglected threat to global emergency state.
P2860
Q23922910-A20D3F72-C897-45F5-A57E-4DCC18BADDF9Q24049114-D22F5262-CF2D-4D18-9C87-3382C4ECCEC8Q24247077-0388749F-48F9-4A7F-ABFB-86CEFE5DAEACQ24261399-B1A956F7-BEDD-4172-9A4B-3CB1E23EE7ABQ24289279-008815D1-6827-4809-8A27-B5BAC1D49436Q24289281-8FE5F0C0-A360-4C82-8053-E40DD16D771CQ24289295-3E53692A-65A5-4BB8-B1DD-5481BA823C29Q24658595-E413496F-6E5E-4542-80CC-E6592EC548E2Q26250274-1306607E-4224-4F78-A98A-A1577DC53EC8Q26775792-2A2A820C-6B92-4AE4-BA26-0AF6CD4BBD5FQ26777336-E8D08162-41FF-4018-B0BD-6EC8894BA8C1Q27011190-010BFEA7-97CD-4F70-9CB2-68C1CF9AB6A6Q27077202-62BCCC8F-7DAF-4C14-96AA-7BFFBE270151Q27318406-6D2B98E1-AFD5-408B-80C4-FF5C4598B715Q28051937-8B36AFED-4F0B-4576-B49E-980CDEC463A1Q28119690-A52B85CD-C461-4A63-A49E-42866A36EF71Q28223031-02FA28CA-D4E1-41F1-9E0D-3B6BE0CC2660Q28385386-9DF1F671-1C8D-434C-9C41-376139E3E68BQ28388002-19515207-FB24-4B81-979E-EA4CE0C2135EQ28389947-62DED14F-AED8-4B37-862A-2A649A86EEF9Q28393073-92053C2D-9A99-4978-9462-1AE0B9C908E9Q28397866-708CFF89-2875-4600-9A81-DAE51CECCA40Q28596689-960BD001-8BE9-457C-90FD-9FBFF837E270Q28822525-6415D0DD-23E4-4BE2-BFFF-78EB54D9F387Q28950587-8BA0CDB7-D6F9-4B57-A2D2-A63F56DD8FB8Q29048611-10F16B69-C320-45D7-8565-D000181B814AQ29451722-299427B3-FC40-4804-AE88-292548B45A38Q29994641-BA0301E5-4776-480E-99E1-A0B8077617A0Q29994671-709715FB-C52B-40F2-98B9-368BFE6B271FQ30151375-3FF4D51E-D86B-462E-8559-EFDBBC1CD7DBQ30151742-4BA98056-71CD-4C37-9690-81CAE352D422Q30196556-2524E90B-AE25-477E-9EC9-8E19D3848E3CQ30201997-A2387B2E-BF92-4DC2-B7B3-FAAC38191351Q30234590-A446541A-D00F-4810-AD32-27D802B95D04Q30234637-AA7F058B-CC50-42B9-9281-DFB6343517AFQ30234872-1310CD70-5502-478E-B792-07447DE6BDE5Q30235073-EA20C954-A2DF-46C4-9319-26B0AEA23F59Q30235612-3D052DF0-F1D6-4A4F-AC3A-BE2714DFB9B2Q30245073-2E9F54A4-8CF8-44E1-BE5B-CF52435BEC45Q30245153-BDE0D394-1E85-4FEA-9701-7CF43F2E28F4
P2860
Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial.
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Efficacy and effectiveness of ...... tion cluster-randomised trial.
@ast
Efficacy and effectiveness of ...... tion cluster-randomised trial.
@en
Efficacy and effectiveness of ...... tion cluster-randomised trial.
@nl
type
label
Efficacy and effectiveness of ...... tion cluster-randomised trial.
@ast
Efficacy and effectiveness of ...... tion cluster-randomised trial.
@en
Efficacy and effectiveness of ...... tion cluster-randomised trial.
@nl
prefLabel
Efficacy and effectiveness of ...... tion cluster-randomised trial.
@ast
Efficacy and effectiveness of ...... tion cluster-randomised trial.
@en
Efficacy and effectiveness of ...... tion cluster-randomised trial.
@nl
P2093
P50
P921
P1433
P1476
Efficacy and effectiveness of ...... tion cluster-randomised trial.
@en
P2093
Aboubacar Soumah
Andrea S Vicari
Bertrand Draguez
Godwin Enwere
Mandy Kader Kondé
Miles W Carroll
Moussa Doumbia
Rebecca Grais
Sakoba Kéïta
Sema Mandal
P304
P356
10.1016/S0140-6736(15)61117-5
P407
P50
P577
2015-08-03T00:00:00Z